TF and leishmaniasis: These genes could be considered for a future rational therapeuticstrategy for leishmaniasis that could include the combination of canonicalanti-leishmanial compounds and host-directed therapy containing moleculesinterfering with some of these genes/proteins from host cells; thisnew therapeutic strategy could increase the efficacy of chemotherapyand the life of anti-parasitic drugs and will decrease the TF in patientswith leishmaniasis.